Glycemic control with Glyburide/Metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial
- 15 February 2004
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 116 (4) , 223-229
- https://doi.org/10.1016/j.amjmed.2003.07.022
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Long-Term Efficacy of Triple Oral Therapy for Type 2 Diabetes MellitusEndocrine Practice, 2002
- National Pharmacy Cardiovascular Council Treatment Guidelines for the Management of Type 2 Diabetes Mellitus: Toward Better Patient Outcomes and New Roles for PharmacistsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002
- Mixed Hepatocellular–Cholestatic Liver Injury after Pioglitazone TherapyAnnals of Internal Medicine, 2002
- The Effect of a Thiazolidinedione Drug, Troglitazone, on Glycemia in Patients with Type 2 Diabetes Mellitus Poorly Controlled with Sulfonylurea and Metformin: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAnnals of Internal Medicine, 2001
- Troglitazone ADD-on Therapy to a Combination of Sulfonylureas Plus Metformin Achieved and Sustained Effective Diabetes ControlEndocrine Practice, 2000
- Combining sulfonylureas and other oral agentsThe American Journal of Medicine, 2000
- Hepatic Failure in a Patient Taking RosiglitazoneAnnals of Internal Medicine, 2000
- Hepatocellular Injury in a Patient Receiving Rosiglitazone: A Case ReportAnnals of Internal Medicine, 2000
- Pharmacologic Therapy for Type 2 Diabetes MellitusAnnals of Internal Medicine, 1999
- Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49)JAMA, 1999